News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-20 4:2:57 am BioLineRx to Report 2023 Annual Financial Results on March 26, 2024 PRNewsWire
2024-03-04 4:0:0 am BioLineRx Strengthens Intellectual Property Estate with Notice of Allowance for U.S. Patent Covering Method of Manufacturing Motixafortide (BL-8040) Suitable for Large Scale Production PR Newswire
2024-02-28 4:0:0 am BioLineRx Announces First Patient Dosed in Randomized Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) PR Newswire
2024-02-26 5:27:0 am BLRX: Poster Presentations Zacks Small Cap Research
2024-02-25 11:12:12 am 3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond InvestorPlace
2024-02-16 4:0:0 am BioLineRx Announces Acceptance of Two Poster Presentations on APHEXDA® (motixafortide) for CD34+ Hematopoietic Stem Cell (HSC) Mobilization in Patients with Multiple Myeloma at the 2024 Tandem Meetings of ASTCT® and CIBMTR® PR Newswire
2023-12-21 4:0:0 am BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information